Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross® Expander System & Retrieval Sheath (NCT05400980)

🧪 Interventions in This Study

• Urocross implant (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• Loyola University Medical Center — Maywood, Illinois
• Virginia Tech-Carilion School of Medicine — Roanoke, Virginia

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Benign Prostatic Hyperplasia

• PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs — La Mesa, California
• Comparing UroLift Experience Against Rezūm — Los Angeles, California
• Optilume™ BPH Catheter System in Men With Symptomatic BPH — Little Rock, Arkansas
• Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate — Miami, Florida
• Laser Prostatectomy Database and Registry — Indianapolis, Indiana

Explore by condition: All Benign Prostatic Hyperplasia clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.